Published in Scand J Haematol on July 01, 1978
Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts. N Engl J Med (2011) 7.89
Mutations and prognosis in primary myelofibrosis. Leukemia (2013) 3.13
Deregulated gene expression pathways in myelodysplastic syndrome hematopoietic stem cells. Leukemia (2010) 2.30
Frequent mutation of the polycomb-associated gene ASXL1 in the myelodysplastic syndromes and in acute myeloid leukemia. Leukemia (2010) 2.23
Oxytocin nasal spray in fibromyalgic patients. Rheumatol Int (2014) 2.22
Chikungunya in north-eastern Italy: a summing up of the outbreak. Euro Surveill (2007) 2.07
Allogeneic hemopoietic SCT for patients with primary myelofibrosis: a predictive transplant score based on transfusion requirement, spleen size and donor type. Bone Marrow Transplant (2009) 2.03
Survival and prognosis among 1545 patients with contemporary polycythemia vera: an international study. Leukemia (2013) 1.97
Guidelines for the use of recombinant human erythropoietin. Haematologica (1995) 1.94
Symptom variability in patients with severe COPD: a pan-European cross-sectional study. Eur Respir J (2010) 1.78
Life expectancy and prognostic factors in the classic BCR/ABL-negative myeloproliferative disorders. Leukemia (2008) 1.77
Flexible guideline-based patient careflow systems. Artif Intell Med (2001) 1.77
Interpretation of measured red cell mass and plasma volume in adults: Expert Panel on Radionuclides of the International Council for Standardization in Haematology. Br J Haematol (1995) 1.70
A telemedicine support for diabetes management: the T-IDDM project. Comput Methods Programs Biomed (2002) 1.69
Outdoor air pollution, climatic changes and allergic bronchial asthma. Eur Respir J (2002) 1.64
A case study in ontology library construction. Artif Intell Med (1995) 1.60
A randomized double-blind placebo-controlled study with subcutaneous recombinant human erythropoietin in patients with low-risk myelodysplastic syndromes. Br J Haematol (1998) 1.55
A Web-based system for the intelligent management of diabetic patients. MD Comput (1997) 1.53
Intravenous iron therapy for severe anaemia in systemic-onset juvenile chronic arthritis. Lancet (1994) 1.52
Guideline-based careflow systems. Artif Intell Med (2000) 1.51
Adaptive controllers for intelligent monitoring. Artif Intell Med (1995) 1.51
Deletions of the transcription factor Ikaros in myeloproliferative neoplasms. Leukemia (2010) 1.51
Night-time symptoms: a forgotten dimension of COPD. Eur Respir Rev (2011) 1.50
Low-molecular-weight heparin versus warfarin for secondary prophylaxis of venous thromboembolism: a cost-effectiveness analysis. Am J Med (2001) 1.49
Subcutaneous erythropoietin for treatment of refractory anemia in hematologic disorders. Results of a phase I/II clinical trial. Blood (1992) 1.49
Clinical severity and molecular typing of human rhinovirus C strains during a fall outbreak affecting hospitalized patients. J Clin Virol (2009) 1.47
An observational study of venoplasty in patients with multiple sclerosis. Can J Neurol Sci (2013) 1.46
Flow cytometry evaluation of erythroid dysplasia in patients with myelodysplastic syndrome. Leukemia (2006) 1.45
NEOANEMIA: a knowledge-based system emulating diagnostic reasoning. Comput Biomed Res (1990) 1.41
Clinical management of myelodysplastic syndromes: update of SIE, SIES, GITMO practice guidelines. Leuk Res (2010) 1.40
Correlation of rhinovirus load in the respiratory tract and clinical symptoms in hospitalized immunocompetent and immunocompromised patients. J Med Virol (2009) 1.36
Status of malaria vectors in Italy. J Med Entomol (1997) 1.33
Evidence-based careflow management systems: the case of post-stroke rehabilitation. J Biomed Inform (2002) 1.29
Protocol-based reasoning in diabetic patient management. Int J Med Inform (1999) 1.28
Quantitative evaluation of erythropoietic activity in dysmyelopoietic syndromes. Br J Haematol (1982) 1.27
Encephalitis without meningitis due to sandfly fever virus serotype toscana. Clin Infect Dis (2001) 1.26
MPN-associated myelofibrosis (MPN-MF). Leuk Res (2010) 1.25
The M2DM Project--the experience of two Italian clinical sites with clinical evaluation of a multi-access service for the management of diabetes mellitus patients. Methods Inf Med (2006) 1.22
A patient workflow management system built on guidelines. Proc AMIA Annu Fall Symp (1997) 1.21
Unbalanced X-chromosome inactivation in haemopoietic cells from normal women. Br J Haematol (1998) 1.20
Mining biomedical time series by combining structural analysis and temporal abstractions. Proc AMIA Symp (1998) 1.20
Evidence for a polyclonal nature of the cell infiltrate in sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease). Br J Haematol (1995) 1.19
Splenomegalic immunocytoma with circulating hairy cells. Report of eight cases and revision of the literature. Haematologica (1986) 1.19
Y chromosome controls mating behaviour on Anopheles mosquitoes. Nature (1977) 1.17
Natural history of idiopathic refractory sideroblastic anemia. Blood (1988) 1.17
Long-term survival in childhood acute lymphocytic leukemia in Italy. Cancer (1981) 1.16
A linkage between hereditary hyperferritinaemia not related to iron overload and autosomal dominant congenital cataract. Br J Haematol (1995) 1.15
The 'GGCC' haplotype of JAK2 confers susceptibility to JAK2 exon 12 mutation-positive polycythemia vera. Leukemia (2009) 1.15
Circulation of West Nile virus lineage 1 and 2 during an outbreak in Italy. Clin Microbiol Infect (2012) 1.14
The dysmetabolic iron overload syndrome is clinically and genetically distinct from HFE-related genetic hemochromatosis. Haematologica (1999) 1.14
Supporting tools for guideline development and dissemination. Artif Intell Med (1998) 1.10
Differential HFE allele expression in hemochromatosis heterozygotes. Gastroenterology (2001) 1.09
Correlation of viral load as determined by real-time RT-PCR and clinical characteristics of respiratory syncytial virus lower respiratory tract infections in early infancy. J Clin Virol (2007) 1.09
Effects of diesel exhaust particles on human lung epithelial cells: an in vitro study. Respir Med (2007) 1.09
Flow cytometry evaluation of erythroid and myeloid dysplasia in patients with myelodysplastic syndrome. Leukemia (2005) 1.09
What are RBC-transfusion-dependence and -independence? Leuk Res (2010) 1.09
Clinical severity and thermodynamic effects of iron-responsive element mutations in hereditary hyperferritinemia-cataract syndrome. J Biol Chem (1999) 1.08
Intelligent analysis of clinical time series: an application in the diabetes mellitus domain. Artif Intell Med (2000) 1.07
Use of erythropoietin to increase the volume of autologous blood donated by orthopedic patients. Transfusion (1993) 1.05
Deciding when to intervene: a Markov decision process approach. Int J Med Inform (2000) 1.04
Changing circulation rate of human metapneumovirus strains and types among hospitalized pediatric patients during three consecutive winter-spring seasons. Brief report. Arch Virol (2005) 1.04
Clinical, laboratory and radiographic features in early rheumatoid arthritis. J Rheumatol (1990) 1.03
Leukemia risk models in primary myelofibrosis: an International Working Group study. Leukemia (2012) 1.01
Transferrin saturation, plasma iron turnover, and transferrin uptake in normal humans. Blood (1985) 1.01
Biologic and clinical significance of red cell ferritin. Blood (1983) 1.00
The role of outdoor air pollution and climatic changes on the rising trends in respiratory allergy. Respir Med (2001) 1.00
Performance characteristics of Hemox-Analyzer for assessment of the hemoglobin dissociation curve. Haematologica (1996) 1.00
Technical note: Improved method for rapid DNA extraction of mastitis pathogens directly from milk. J Dairy Sci (2006) 1.00
A framework for building cooperative software agents in medical applications. Artif Intell Med (1999) 1.00
The mechanism of action of methylprednisolone in the treatment of multiple sclerosis. Mult Scler (2005) 0.99
Effect of inhaled bronchodilators on inspiratory capacity and dyspnoea at rest in COPD. Eur Respir J (2003) 0.99
Detection of enterotoxigenic Staphylococcus aureus isolates in raw milk cheese. Lett Appl Microbiol (2007) 0.99
Mucoceles in the paranasal sinuses involving the orbit: CT signs in 43 cases. Neuroradiology (1982) 0.99
Study of the bone pathology in early mucolipidosis II (I-cell disease). Eur J Pediatr (1989) 0.98
Juvenile hemochromatosis locus maps to chromosome 1q. Am J Hum Genet (1999) 0.98
Saporin, a ribosome-inactivating protein used to prepare immunotoxins, induces cell death via apoptosis. Br J Haematol (1996) 0.98
Myelofibrosis with myeloid metaplasia in young individuals: disease characteristics, prognostic factors and identification of risk groups. Br J Haematol (1998) 0.97
Myelodysplastic syndromes: recent advances. Haematologica (2001) 0.97
Incidence and prevalence of multiple sclerosis in Newfoundland and Labrador. Can J Neurol Sci (2005) 0.95
Study of prognosis in Waldenström's macroglobulinemia: a proposal for a simple binary classification with clinical and investigational utility. Blood (1994) 0.95
Qualitative models and fuzzy systems: an integrated approach for learning from data. Artif Intell Med (1998) 0.95
Juvenile idiopathic haemochromatosis: a life-threatening disorder presenting as hypogonadotropic hypogonadism. Hum Genet (1983) 0.94
Apoptosis: biological and clinical aspects. Haematologica (2004) 0.94
Potential vectors of West Nile virus following an equine disease outbreak in Italy. Med Vet Entomol (2004) 0.93
Iron loading in congenital dyserythropoietic anaemias and congenital sideroblastic anaemias. Br J Haematol (1983) 0.93
A performance evaluation of the expert system ANEMIA. Comput Biomed Res (1988) 0.93